{"id":59213,"date":"2020-11-11T14:15:45","date_gmt":"2020-11-11T19:15:45","guid":{"rendered":"https:\/\/rarediseases.org\/nord-c-path-present-3-part-video-series-on-challenges-of-rare-disease-drug-development-how-rdca-dap-can-help\/"},"modified":"2020-11-11T14:15:45","modified_gmt":"2020-11-11T19:15:45","slug":"nord-c-path-present-3-part-video-series-on-challenges-of-rare-disease-drug-development-how-rdca-dap-can-help","status":"publish","type":"post","link":"https:\/\/rarediseases.org\/es\/nord-c-path-present-3-part-video-series-on-challenges-of-rare-disease-drug-development-how-rdca-dap-can-help\/","title":{"rendered":"NORD &#038; C-Path Present 3-Part Video Series on Challenges of Rare Disease Drug Development, How RDCA-DAP Can Help"},"content":{"rendered":"<p><span data-contrast=\"none\">There are five steps in the drug development process, which are designed to help ensure that potential new therapies are both safe and effective.\u00a0Developing medical products for rare diseases encounters many challenges throughout this\u00a0process. The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) is being developed by NORD and the Critical Path Institute (C-Path) to help overcome these hurdles.\u00a0<\/span><span data-contrast=\"none\">The goal of the\u00a0<\/span><span data-contrast=\"none\">RDCA-DAP is<\/span><span data-contrast=\"none\">\u00a0to help<\/span><span data-contrast=\"none\">\u00a0contribute to faster development of medications for rare diseases, 90% of which are still without an FDA-approved treatment.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Together, NORD and C-Path have created \u201cAccelerating Rare Disease Drug Development,\u201d a three-part video series<\/span><span data-contrast=\"none\">\u00a0<\/span><span data-contrast=\"none\">examin<\/span><span data-contrast=\"none\">in<\/span><span data-contrast=\"none\">g<\/span><span data-contrast=\"none\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">T<\/span><span data-contrast=\"none\">he\u00a0basics of the drug development\u00a0process<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"none\">T<\/span><span data-contrast=\"none\">he\u00a0challenges\u00a0of developing therapies for rare\u00a0<\/span><span data-contrast=\"none\">diseases<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"none\">H<\/span><span data-contrast=\"none\">ow<\/span><span data-contrast=\"none\"> RDCA-DAP can\u00a0help to\u00a0streamline\u00a0and speed the journey to rare disease cures and treatments\u00a0throughout the five stages of the drug development process<\/span><span data-contrast=\"none\">\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">Watch\u00a0the<\/span><span data-contrast=\"none\">\u00a0\u201cAccelerating Rare Disease Drug Development\u201d<\/span><span data-contrast=\"none\">\u00a0video<\/span><span data-contrast=\"none\">\u00a0series<\/span><span data-contrast=\"none\">\u00a0or learn more about the RDCA-DAP<\/span><span data-contrast=\"none\">\u00a0<a href=\"https:\/\/rarediseases.org\/rdca-dap\/\">here<\/a>.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<div style=\"padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%;\" src=\"https:\/\/vimeo.com\/showcase\/7776866\/embed\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n","protected":false},"excerpt":{"rendered":"<p>There are five steps in the drug development process, which are designed to help ensure that potential new therapies are both safe and effective.\u00a0Developing medical products for rare diseases encounters &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/rarediseases.org\/es\/nord-c-path-present-3-part-video-series-on-challenges-of-rare-disease-drug-development-how-rdca-dap-can-help\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NORD &#038; C-Path Present 3-Part Video Series on Challenges of Rare Disease Drug Development, How RDCA-DAP Can Help&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[190,192,2427,193],"tags":[2037,2366,2557,2460,2036,2558],"class_list":["post-59213","post","type-post","status-publish","format-standard","hentry","category-featured-news","category-patients-members","category-rdca-dap","category-research","tag-c-path","tag-critical-path-institute","tag-rare-disease-cures","tag-rare-disease-drug-development","tag-rdca-dap","tag-the-rare-disease-cures-accelerator-data-and-analytics-platform"],"acf":[],"_links":{"self":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/59213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/comments?post=59213"}],"version-history":[{"count":0,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/59213\/revisions"}],"wp:attachment":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media?parent=59213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/categories?post=59213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/tags?post=59213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}